WASHINGTON D.C., May 8, 2019 – Baker Botts, L.L.P., a leading international law firm, today announced that firm client PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, and Perrigo Animal Health today announced they have executed a definitive agreement under which PetIQ will acquire Perrigo Animal Health, a manufacturer of vet quality products for pet parents, from Perrigo Company plc (NYSE; TASE: PRGO) in an $185 million cash transaction. The transaction is subject to customary closing conditions, including regulatory approval. A link to the PetIQ press release can be found here.
Baker Botts is handling antitrust for PetIQ on the deal. The Baker Botts antitrust team is led by antitrust group Co-Chair Steve Weissman, assisted by Senior Associate Christine Ryu-Naya. Both are residents in the firm’s Washington D.C. office. The Baker Botts team worked closely with Winston & Strawn, which handled the corporate aspects of the transaction for PetIQ.
ABOUT BAKER BOTTS L.L.P.
Baker Botts is an international law firm of approximately 650 lawyers practicing throughout a network of offices around the globe. Based on our experience and knowledge of our clients' industries, we are recognized as a leading firm in the energy, technology, and life sciences sectors. Since 1840, we have provided creative and effective legal solutions for our clients while demonstrating an unrelenting commitment to excellence. For more information, please visit bakerbotts.com.